FDA.reportPublic FDA data

tovorafenib 400 MG Weekly Dose Carton Pack, 100 MG Oral Tablet 16 Count Pack

RxCUI
2690857
RxNorm name
tovorafenib 400 MG Weekly Dose Carton Pack, 100 MG Oral Tablet 16 Count Pack
Display name
tovorafenib 400 MG Weekly Dose Carton Pack, 100 MG Oral Tablet 16 Count Pack
Full name
tovorafenib 400 MG Weekly Dose Carton Pack, 100 MG Oral Tablet 16 Count Pack
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OJEMDATOVORAFENIBDay One Biopharmaceuticals, Inc.ea3a9631-3a66-6a7c-e053-2995a90ae2ad2025-09-02Warnings, Adverse reactionsExact identifier
rxcui: 2690857

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ea3a9631-3a66-6a7c-e053-2995a90ae2ad{16 (tovorafenib 100 MG Oral Tablet) } Pack [GPCK] · tovorafenib 400 MG Weekly Dose Carton Pack, 100 MG Oral Tablet 16 Count Pack [PSN] · tovorafenib 400 MG Weekly Dose Carton Pack, 4 Blister Cards, 4 Tablets Each [SY]39These highlights do not include all the information needed to use OJEMDA safely and effectively. See full prescribing information for OJEMDA. OJEMDA (tovorafenib) tablets, for oral use OJEMDA (tovorafenib) for oral suspension Initial U.S. Approval: 202420250902